Insulin Types for Diabetes: Complete Guide to Onset, Peak, Duration, and Use
Insulin therapy is tailored using formulations with distinct pharmacokinetic profiles. All times are approximate; individual variation exists.
| Type | Examples | Onset | Peak | Duration | Primary Use |
|---|---|---|---|---|---|
| Rapid-acting | Lispro, Aspart, Glulisine | 15 min | 1–2 h | 3–5 h | Mealtime, correction |
| Short-acting (Regular) | Humulin R, Novolin R | 30–60 min | 2–4 h | 5–8 h | Mealtime (less used now) |
| Intermediate (NPH) | Humulin N, Novolin N | 1–2 h | 4–12 h | 12–18 h | Basal, BID |
| Long-acting (Basal) | Glargine U100/U300, Detemir, Degludec | 1–2 h | Flat/none | 24–42 h | Once-daily basal |
| Premixed | 70/30, 50/50, 75/25 | Varies | Dual | Varies | Fixed ratio, BID |
| Concentrated | U200, U300, U500 | Varies | Varies | Extended | High insulin resistance |
Key Clinical Pearls
- Rapid-acting analogs preferred over regular for mealtime (faster on/off).
- Long-acting basal analogs (glargine, degludec) have lower hypoglycemia risk than NPH.
- Degludec U200/U300: ultra-long, flexible dosing window.
- Inhaled insulin (Afrezza): ultra-rapid, mealtime only.
- Pump therapy: Uses rapid-acting only for both basal (continuous) and bolus.
Regimen selection requires endocrinologist/diabetes educator collaboration.
Diabetes - Related Articles
- Understanding the Risks of Uncontrolled Diabetes: Causes & Complications
- Diabetes & Kidney Disease: Dietary Strategies for Optimal Health
- Heart-Healthy Eating for Diabetes: A Comprehensive Guide
- Managing High Blood Sugar: Understanding and Lowering Glucose Levels
- Metformin Safety: Understanding Side Effects and Risks
- Understanding Blood Sugar Levels: A Guide for Diabetes Management
- Numbness and Diabetes: Understanding Diabetic Neuropathy
